KREBSBIO

Krebs Biochemicals and Industries Limited

Source: NSE · Updated 4 Nov, 06:28 pm IST

Filed 29 Oct, 02:12 pm IST Q2 FY27 (Sep ’26)Standalone (no consolidated filing)₹ lakhs

Revenue

579.03

▲ 38.9% vs Q2 FY26

Operating profit (EBITDA, derived from filing)

-192.87

vs Q2 FY26: n/a

Net profit

-539.85

vs Q2 FY26: n/a

EPS (₹)

-2.50

vs Q2 FY26: n/a

Operating margin

-33.3%

+3370 bps vs Q2 FY26

Net margin

-93.2%

+5420 bps vs Q2 FY26

Loss narrowed vs Q2 FY26

Revenue+39% vs Q2 FY26 · −17% vs Q1 FY27

ProfitLoss narrowed vs Q2 FY26 · Loss widened vs Q1 FY27

View official filing ↗

Numbers from the company's structured XBRL filing on NSE, cross-checked with P&L totals.

Previous-quarter and year-ago figures: as originally reported in those quarters' NSE filings; filing PDF not available to confirm restatements.

Quarter comparison

Item	Q2 FY27 (Sep ’26)	Q1 FY27 (Jun ’26)	vs Q1 FY27	Q2 FY26 (Sep ’25)	vs Q2 FY26
Revenue from operations	579.03	698.35	▼ 17.1%	416.74	▲ 38.9%
Other income	3.74	15.65	▼ 76.1%	0.67	▲ 458.2%
Total income	582.77	714	▼ 18.4%	417.41	▲ 39.6%
Total expenses	1,122.62	962.48	▲ 16.6%	1,031.69	▲ 8.8%
Operating profit (EBITDA)*	-192.87	82.7	—	-279.23	—
Profit before tax	-539.85	-248.48	—	-614.28	—
Tax expense	0	0	—	0	—
Net profit	-539.85	-248.48	—	-614.28	—
EPS (₹)	-2.50	-1.15	—	-2.85	—
Operating margin	-33.3%	11.8%	−4510 bps	-67.0%	+3370 bps
Net margin	-93.2%	-35.6%	−5760 bps	-147.4%	+5420 bps

Showing Q2 FY27 (Sep ’26) and change vs Q2 FY26. Turn your phone sideways for Q1 FY27 (Jun ’26).

Figures in ₹ lakhs except EPS. Standalone figures from the company's XBRL filing on NSE. Each row is shown only if it reconciles with the others (e.g. PBT − tax = net profit); rows we couldn't verify are left out. Net margin = net profit ÷ revenue. *Operating profit (EBITDA), derived from the filing: profit before exceptional items and tax + finance costs + depreciation − other income. Operating margin = EBITDA ÷ revenue.

All Krebs Biochemicals and Industries results, dividends & filings ›

Other results filed 29 Oct

ACI Archean Chemical Industries Limited›KALPATARU Kalpataru Limited›SUDARSHAN Sudarshan Pharma Industries Limited›STLNETWORK STL Networks Limited›LAURUSLABS Laurus Labs Limited›SURYODAY Suryoday Small Finance Bank Limited›ARCIL Asset Reconstruction Company (India) Limited›RBA Restaurant Brands Asia Limited›ASIANPAINT Asian Paints Limited›MONARCH Monarch Networth Capital Limited›CARERATING CARE Ratings Limited›AYMSYNTEX AYM Syntex Limited›

Today's results ›

KREBS BIOCHEMICALS AND INDUSTRIES Q2 FY27 ; NET LOSS OF ₹5.40 CR VS LOSS ₹6.14 CR (YOY), LOSS ₹2.48 CR (QOQ)

REVENUE UP 39% AT ₹5.79 CR (YOY), DOWN 17% (QOQ)

EBITDA LOSS OF ₹1.93 CR VS LOSS ₹2.79 CR (YOY), EBITDA ₹0.83 CR (QOQ)

MARGINS AT -33.3% VS -67.0% (YOY), 11.8% (QOQ)

https://resultkal.com/r/krebsbio-2026-10-29
Source: NSE filing · not investment advice

FAQ

When did Krebs Biochemicals and Industries announce Q2 FY27 results?

Krebs Biochemicals and Industries filed its results on NSE on 29 Oct, 02:12 pm IST.

What does QoQ and YoY mean?

QoQ compares with the previous quarter; YoY compares with the same quarter last year. Growth is calculated from the figures in the filing.

Are these Krebs Biochemicals and Industries figures official?

They are auto-read from the company's NSE filing and may contain errors. Always confirm with the official PDF linked on this page.

Explore

Today's results Results this week Q2 FY27 results dates Dividend stocks this week Bonus issue 2026 Stock split 2026

Figures are auto-read from the company's NSE filing and may contain errors. Check the official filing before deciding. Not investment advice.

← KREBSBIO overview